JDA Software Highlights Supply Chain Opportunities for Pharmaceutical Manufacturers and Distributors
September 03 2009 - 8:00AM
Business Wire
Successful supply chain management, including managing demand,
planning API and formulation production, packaging and
distributing, is a goal shared by all pharmaceutical manufacturers.
According to PharmaTech.com, effective supply-chain management is
particularly important as the pharmaceutical industry seeks ways to
reduce costs, maintain regulatory compliance, and adhere to quality
and safety standards.1
The challenges affecting pharmaceutical manufacturers,
distributors and retailers are among the critical topics to be
addressed by leading industry professionals at the Pharma
Manufacturers Arena’s first global virtual event on September 9 and
10, 2009.
During the conference, David Johnston, senior vice president,
manufacturing and distribution, JDA Software, will
discuss how pharmaceutical manufacturers can embrace supply chain
solutions and innovative strategies to grow a diversified global
business, achieve collaborative visibility, reduce costs and
improve profitability. Johnston’s presentation, entitled
“Diversification and the Important Role that a Highly Efficient
Supply Chain Plays in Driving Profit,” will be held on Wednesday,
Sept. 9, from 12:20 to 12:50 p.m. EDT. JDA will share insight on
how expiring patents, globalization of the pharmaceutical products
markets and increased competition are all factors that can affect
the bottom line. By leveraging advanced technology solutions and
growing diversified, risk-balanced product portfolios,
pharmaceutical manufacturers can deliver more products of value,
streamline operations and deliver shareholder value, as well as
sustain profitability during economic uncertainties.
Prescription for Supply Chain Success
JDA recognizes that even successful pharmaceutical corporations
are not immune to the ever-increasing demands and expectations of
the highly competitive pharmaceutical industry. For example, Merck
Serono International S.A., an internationally known biotechnology
leader, understands the value of leveraging processes and solutions
that drive one synchronized view of demand. After creating one
centrally managed supply chain driven by advanced supply chain
optimization solutions from JDA Software, the pharmaceutical giant
benefited from a 20-percent reduction in global stock levels;
having a single view of demand across the supply chain; a decrease
in manufacturing costs; improved demand forecast accuracy; and
optimized production across the company’s supply chain network.
To help pharmaceutical companies achieve one synchronized view
of demand, JDA offers the following five strategies based on
industry best practices that can enable them to improve forecast
accuracy and manufacturing planning, as well as drive production
efficiency and optimize business operations for maximum ROI and
profitable growth:
- Diversify product
portfolios: With approximately 100 pharmaceutical patents set
to expire in 2009 alone, the pharmaceutical industry will see over
$60 billion of annual income washed away by 2014 due to patent
erosion. To maintain a competitive advantage, pharmaceutical
manufacturers need to diversify their product portfolios to deliver
more value to existing and emerging markets. And although
diversified product portfolios usually require more financial
reviews to make profitable tradeoff decisions, a diversified and
risk-balanced product portfolio will help to build stability into
the business models of pharmaceutical manufacturers.
- Implement robust demand
management: To achieve strategic business objectives,
pharmaceutical manufacturers need highly precise sales forecasts to
pinpoint and predict demand with the highest level of accuracy,
effectively driving the production and distribution of their
products in an optimized way. With robust demand management
processes securely in place, pharmaceutical manufacturers can
improve sales forecasting accuracy, drive production efficiencies
and minimize inventory carrying costs, resulting in more profitable
decisions.
- Embrace collaborative
visibility: Required for consensus demand planning and growth
through partnering, collaborative visibility is the new business
model for expansion in the pharmaceutical industry. With a shared
visibility between demand planners, sales, marketing and business
partners, you will better understand your operations and
effectively coordinate your business activity with partners,
suppliers and customers. With a comprehensive understanding of
business performance and a better plan for collaboration,
pharmaceutical manufacturers can maximize revenue and expand
through collaborative partnerships with other companies.
- Right-size your
inventory: To ensure costs are managed as product portfolios
grow, pharmaceutical manufacturers need to focus on right-sizing
their inventories and improving service levels. With the ongoing
recession, many companies were caught off guard with the sudden
downturn of business and inventory excess. Manufacturers need to
understand the role that their pharmaceutical products play in
terms of revenue and potential growth, carefully examining how to
leverage that inventory to meet strategic objectives.
- Leverage the power of an
integrated sales and operations planning (S&OP) solution:
For today’s dynamic global market, a robust S&OP process is a
must for pharmaceutical manufacturers to gain the ability to
integrate time-phased revenue, cost and margin plans with
operational plans to gain market share, increase profit and achieve
significant improvements in overall business performance. An
integrated S&OP solution provides significant benefits by
reducing resources spent collecting data, analyzing reports and
building spreadsheets, as well as provides forward-looking views of
the business to support the appropriate product, demand, supply,
financial and management reviews in a graphical format that quickly
identifies business impacts, allowing for rapid and informed
decision making.
To learn more about how JDA Software helps pharmaceutical
manufacturers, distributors and retailers achieve supply chain
visibility, improve operational efficiencies, strengthen brands,
and predict demand more accurately, please visit www.jda.com.
About JDA Software Group, Inc.
JDA® Software Group, Inc. (NASDAQ: JDAS) is the world’s leading
supply chain solutions provider, helping companies optimize
operations and improve profitability. JDA drives business
efficiency for its global customer base of more than 5,800
retailers, manufacturers, wholesaler-distributors and services
industries companies through deep domain expertise and innovative
solutions. JDA's combination of unmatched services, together with
its integrated yet modular solutions for merchandising, supply
chain planning and execution and revenue management, leverage the
strong heritage and knowledge capital of market leaders including
Manugistics, E3, Intactix and Arthur. When supply chain results
matter, companies turn to JDA. For more information about JDA,
visit www.jda.com or contact us at info@jda.com or call +1 800 479
7382/+1 480 308 3000.
This press release contains forward-looking statements that are
made in reliance upon the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements are generally accompanied by words such as “will,”
“can,” “ensure,” “help,” “enable” and “expect” and other words with
forward-looking connotations. In this press release, such
forward-looking statements include, without limitation, remarks
that leveraging advanced technology solutions can deliver more
profitability and certain benefits to pharmaceutical companies. The
occurrence of future events may involve a number of risks and
uncertainties, including, but not limited to: (a) our solutions may
not perform exactly as we anticipate; (b) there may be
implementation and integration problems associated with our
solutions; and (c) other risks detailed from time to time in the
“Risk Factors” section of our filings with the Securities and
Exchange Commission. Additional information relating to the
uncertainty affecting our business is contained in our filings with
the SEC. As a result of these and other risks, actual results may
differ materially from those predicted. JDA is not under any
obligation to (and expressly disclaims any such obligation to)
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
“JDA” is a registered trademark of JDA Software Group. Any
trade, product or service name referenced in this document using
the name "JDA" is a trademark and/or property of JDA Software
Group. All other trade, product, or service names referenced in
this release may be trademarks or registered trademarks of their
respective holders.
1 Best Practices in the Supply Chain, Pharmaceutical Technology
Sourcing and Management, PharmaTech.com, Patricia Van Arnum, June
8, 2009
Jda (NASDAQ:JDAS)
Historical Stock Chart
From May 2024 to Jun 2024
Jda (NASDAQ:JDAS)
Historical Stock Chart
From Jun 2023 to Jun 2024